1. Signaling Pathways
  2. Immunology/Inflammation
  3. CX3CR1

CX3CR1 (CX3C趋化因子受体1)

CX3C chemokine receptor1; GPR13; fractalkine receptor

CX3C 趋化因子受体 1 (CX3CR1),也称为分形因子受体或 GPR13,是 CX3CL1 的特异性受体。顾名思义,CX3CR1 可与趋化因子 CX3CL1(也称为分形因子(在人类中)或神经触素(在小鼠中))结合。CX3CL1 是 CX3C 家族的成员,已在活化的内皮细胞、平滑肌细胞 (SMC)、巨噬细胞和血小板上检测到。CX3CL1 是体内唯一具有促炎、抗炎和神经保护作用的神经元趋化因子,并参与多种炎症病理的发展,包括动脉粥样硬化、类风湿性关节炎或移植排斥。

CX3C chemokine receptor1 (CX3CR1), also known as the fractalkine receptor or GPR13, is the specific receptor to the CX3CL1. As the name suggests, CX3CR1 binds the chemokine CX3CL1 (also called fractalkine (in humans) or neurotactin (in mouse) ). CX3CL1 is a member of the CX3C family and that has been detected on activated endothelial cells, smooth muscle cells (SMCs), macrophages and platelets. CX3CL1 is the only neuronal chemokine in the body with pro-inflammatory, anti-inflammatory and neuroprotective effects, and is involved in the development of numerous inflammatory pathologies including atherosclerosis, rheumatoid arthritis, or graft rejection.

CX3CR1 相关产品 (4):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-13848
    AZD8797 99.54%
    AZD8797 (KAND567) 是非竞争性、可口服的人 CX3CR1 变构拮抗剂,拮抗 CX3CR1CXCR2Ki 分别为 3.9 和 2800 nM。
    AZD8797
  • HY-123918
    JMS-17-2 99.59%
    JMS-17-2 是一种有效的选择性 CX3CR1 拮抗剂,IC50 为 0.32 nM。JMS-17-2 降低乳腺癌细胞的转移和定植。
    JMS-17-2
  • HY-107456
    E6130 ≥98.0%
    E6130 是一种具有口服活性的,高度选择性的 CX3CR1 调节剂,有研究炎症性肠病的潜力。
    E6130
  • HY-123918A
    JMS-17-2 hydrochloride
    JMS-17-2 hydrochloride 是一种有效的选择性 CX3CR1 拮抗剂,IC50 为 0.32 nM。JMS-17-2 hydrochloride 降低乳腺癌细胞的转移和定植。
    JMS-17-2 hydrochloride